As with most drug pricing battles, patients yet again are caught in the crossfire.
GCI Health, HealthyWomen, and Redbook magazine are using survey insights to inform the HealthiHer movement.
Actor Patrick Dempsey is helping patients get over the pressure of scheduling an appointment
The 2017 numbers aren't kind to print-first publishers. Is this a blip in print's fortunes or the start of a long-predicted decline?
Alok Sonig, chief executive officer of developed markets at Dr. Reddy's Laboratories, articulates the benefits of generics.
He spent more than 30 years at the pharmaceutical company.
In an unusual twist, the makers of cholesterol drug Praluent are re-pricing the treatment to align with the nonprofit's recommendation. Is industry warming to ICER?
Why the drugmaker's partnership with a YouTube star is still getting hits.
As drugmakers continue to experiment with novel pricing models for expensive new specialty drugs, MM&M asked a trio of industry insiders whether outcomes-based pricing should become standard.
Direct-to-consumer drug marketing spend dropped most heavily in the magazine and digital categories.